No abstract available
Keywords:
COVID-19; Kawasaki-like syndrome; multisystem inflammatory syndrome; pediatric inflammatory multisystem syndrome.
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
COVID-19 / complications*
-
COVID-19 / diagnosis
-
COVID-19 / etiology
-
COVID-19 / virology
-
Feces / virology*
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Immunologic Factors / therapeutic use
-
Infant
-
Japan
-
Male
-
Mucocutaneous Lymph Node Syndrome / diagnosis
-
Mucocutaneous Lymph Node Syndrome / etiology*
-
Mucocutaneous Lymph Node Syndrome / therapy
-
Patient Readmission
-
Prednisolone / therapeutic use
-
Reverse Transcriptase Polymerase Chain Reaction / methods
-
SARS-CoV-2
-
Systemic Inflammatory Response Syndrome / etiology
-
Treatment Outcome
-
Virus Shedding*
Substances
-
Anti-Inflammatory Agents
-
Immunoglobulins, Intravenous
-
Immunologic Factors
-
Prednisolone
Supplementary concepts
-
pediatric multisystem inflammatory disease, COVID-19 related